| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 102613-21-8 | 3-(3-chloro-4-ethoxybenzyl)-5-fluoro-uraci | |
| |
| 102613-20-7 | 3-butyl-5-(dimethylamino)-1,6-dimethyl-uraci | |
| |
| 102613-19-4 | 1-butyl-5-(dimethylamino)-3,6-dimethyl-uraci | |
| |
| 102613-18-3 | 3-(4-butoxy-3-chlorobenzyl)-5-fluoro-uraci | |
| |
| 102613-17-2 | 3-(3-bromo-6-methoxybenzyl)-5-fluoro-uraci | |
| |
| 102613-16-1 | 3-(3-bromo-4-methoxybenzyl)-5-fluoro-uraci | |
| |
| 102613-15-0 | 3-(3-bromo-4-ethoxybenzyl)-5-fluoro-uraci | |
| |
| 102613-14-9 | 5-allyl-6-methyl-2-thio-uraci | |
| |
| 102613-13-8 | n-(2,3,6,7-tetrahydro-1h,5h-benzo(ij)quinolizin-9-yl)-10-undecenamin dihydr | |
| |
| 102613-12-7 | 9-(2,3,6,7-tetrahydro-1h,5h-benzo(ij)quinolizin-9-yl)-10-undecenamid | |
| |
| 102613-11-6 | n-(4-pyridylmethyl)-10-undecenamid | |
| |
| 102613-10-5 | n-(3-pyridylmethyl)-10-undecenamid | |
| |
| 102613-09-2 | n-(2-pyridylmethyl)-10-undecenamid | |
| |
| 102613-08-1 | n-(3-morpholinopropyl)-10-undecenamid | |
| |
| 102613-07-0 | n-(2-morpholinoethyl)-10-undecenamid | |
| |
| 102613-06-9 | n-morpholino-10-undecenamid | |
| |
| 102613-05-8 | n-(3,4-(methylenedioxy)phenethyl)-10-undecenamid | |
| |
| 102613-04-7 | n-methoxy-n-methyl-10-undecenamid | |
| |
| 102613-03-6 | 11-bromo-n-vanillyl-10-undecenamid | |
| |
| 102613-02-5 | n-(2-bromoallyl)-10-undecenamid | |
| |
| 102613-01-4 | n,n-bis(2-methoxyethyl)-10-undecenamid | |
| |
| 102613-00-3 | 11-isopropylthio-undecanoic aci | |
| |
| 102612-99-7 | 11,11'-dithiobis(n-vanillyl-undecanamid | |
| |
| 102612-98-6 | 10-bromo-n-vanillyl-undecanamid | |
| |
| 102612-97-5 | 10h-thieno(2,3-b)(1,5)benzodiazepine, 4-((2-(dimethylamino)ethyl)amino)-2-ethyl | |
| |
| 102612-96-4 | 2-a)benzimidazole, 4a,5,6,7,8,8a-hexahydro-3-(tert-butyl)-thiazolo( hydrochl | |
| |
| 102612-94-2 | 3-(3-(isobutylamino)propyl)-2-(3,4-methylenedioxyphenyl)-4-thiazolidinon mo | |
| |
| 102612-93-1 | 3-(2-(cyclohexylamino)ethyl)-2-(3,4-methylenedioxyphenyl)-4-thiazolidinon m | |
| |
| 102612-92-0 | (e)-thiazolidin | |
| |
| 102612-91-9 | 2-thiazolidinehexanoic acid, 4-oxo-, sodium salt, hydrate (2:5) | |
| |
| 102612-90-8 | thiazolidine, 2-(2,6-dimethylhepta-1,5-dienyl)- cis and trans mixture | |
| |
| 102612-89-5 | 4-(p-chlorophenyl)-2-(o-methoxybenzylamino)-thiazole-5-acetic aci | |
| |
| 102612-88-4 | thiazole-5-acetic acid, 4-(p-chlorophenyl)-2-(o-hydroxy-alpha-sulfobenzylamino) | |
| |
| 102612-87-3 | 7h-purine-2,6-diol, 8-methyl, monopotassium salt, dihydrate | |
| |
| 102612-86-2 | pseudourea, 2-(2-(morpholinoamino)ethyl)-2-thio- dihydrobromide | |
| |
| 102612-85-1 | 2-methyl-2-thio-3-(2,3-xylyl)-pseudoure hydriodide | |
| |
| 102612-84-0 | 2-methyl-3-(5,6,7,8-tetrahydro-1-naphthyl)-2-thio-pseudoure hydriodide | |
| |
| 102612-83-9 | 1,2-dimethyl-3-(4-methoxy-1-naphthyl)-2-thio-pseudoure hydriodide | |
| |
| 102612-82-8 | 2-(2-(diisobutylamino)ethyl)-2-thio-pseudoure dihydrobromide | |
| |
| 102612-81-7 | n,n-dimethyl-3-(2-(dimethylaminomethyl)norbornan-3-yl)-propylamin | |
| |
| 102612-80-6 | 2,3-dibromo-n,n-diethyl-1-propylamin hydrochloride | |
| |
| 102612-79-3 | 4'-hydroxy-2-morpholino-3-phenyl-propiophenon hydrochloride | |
| |
| 102612-78-2 | 3-(4-allyl-2-methoxy-6-(1-pyrrolidinylmethyl)phenoxy)-3-propanediol | |
| |
| 102612-77-1 | 3-(4-allyl-2-methoxy-6-(morpholinomethyl)phenoxy)-3-propanediol | |
| |
| 102612-76-0 | 3-(4-allyl-2-((isopropylamino)methyl)-6-methoxyphenoxy)-3-propanediol | |
| |
| 102612-75-9 | 3-(4-allyl-2-((dimethylamino)methyl)-6-methoxyphenoxy)-3-propanediol | |
| |
| 102612-73-7 | 3-propanediamine, n,n-bis(2-chloroethyl)-n',n'-dibenzyl- dipicrate | |
| |
| 102612-72-6 | 1,3-propanediamine, n,n-bis(2-chloroethyl)-n',n'-dibenzyl-, n,n'-dioxide, dipic | |
| |
| 102612-70-4 | 2,2-bis(p-methoxyphenyl)-1,3-dichloro-propan | |
| |
| 102612-69-1 | 2-propeneperoxoic acid, 2-methoxyethyl ester | |
| |
